Jane Huang
President chez PRELUDE THERAPEUTICS INCORPORATED
Fortune : 243 246 $ au 31/03/2024
Profil
Le Dr Jane E. Huang, MD, est médecin en chef - hématologie chez BeiGene Ltd. Le Dr. Huang était auparavant employée en tant que vice-présidente et responsable du développement clinique chez Acerta Pharma BV et directrice médicale de groupe chez Genentech, Inc. Elle a obtenu son diplôme de premier cycle à l'université de Stanford et un doctorat à la faculté de médecine de l'université de Washington.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
04/04/2024 | 51 287 ( 0,09% ) | 243 100 $ | 31/03/2024 | |
BEIGENE LTD
0,00% | 17/04/2023 | 12 ( 0,00% ) | 146 $ | 31/03/2024 |
07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Jane Huang
Sociétés | Poste | Début |
---|---|---|
PROTARA THERAPEUTICS, INC. | Director/Board Member | 09/06/2021 |
PRELUDE THERAPEUTICS INCORPORATED | President | 04/04/2022 |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 05/04/2022 |
Anciens postes connus de Jane Huang
Sociétés | Poste | Fin |
---|---|---|
BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | 03/04/2022 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Corporate Officer/Principal | 01/09/2016 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/03/2015 |
Formation de Jane Huang
Stanford University | Undergraduate Degree |
Washington University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
BEIGENE, LTD. | Health Technology |
PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
PROTARA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |